市場調查報告書
商品編碼
1261647
2022-2028 年全球外科吻合器市場規模、份額、行業趨勢分析報告(按類型、產品類型、最終用途、區域展望和預測)Global Surgical Stapling Devices Market Size, Share & Industry Trends Analysis Report By Type, By Product Type, By End-use, By Regional Outlook and Forecast, 2022 - 2028 |
外科吻合器市場規模預計到 2028 年將達到 79 億美元,預測期內復合年增長率為 9.4%。
在許多情況下,外科醫生可能需要了解最佳使用這些技術的科學或臨床基礎,或者如何從特定技術的特定優勢中獲益。 因此,即使設備運行良好,您也可能經常依賴外科醫生的專業知識、判斷力和軼事證據來獲得更好的結果。
手術吻合器是最常用的手術器械之一,其技術幾乎在不斷發展。 儘管這些裝置具有很強的適應性和實用性,但已經有充分記錄的釘線洩漏導致術後困難的案例,其中許多是由於與缺血無關的問題。
外科吻合器越來越重要,尤其是在婦科、胃腸、減肥等高難度手術中。 此外,外科縫合器械的使用促進了新外科技術的發展、現有外科技術的改進和改善的臨床結果。 全球對微創治療的需求不斷增長,正在推動外科縫合設備市場的擴張。
COVID-19 影響分析
許多醫院被迫暫停非緊急門診服務,這對手術吻合器市場產生了重大影響。 社會排斥、人口控制和診所准入限制對市場產生了重大影響。 然而,由於主要製造商專注於引進技術先進的產品以增加市場份額,因此在解除限制後市場預計將大幅增長。 我們還認為,隨著生產重回正軌、手術恢復和需求上升,手術吻合器市場將在大流行之後再次開始擴張。
市場增長因素
外科吻合器的技術改進
外科縫合釘和相關縫合釘的技術發展對醫療保健專業人員對外科縫合裝置的接受度產生了重大影響。 自從引入動力外科縫合器以來,閉合術後傷口所需的時間已經減少,從而最大限度地減少了問題和出血。 在臨床試驗中,動力手術吻合器在癒合速度和不適感方面表現更好。 因此,手術吻合器提供的技術優勢有望推動市場增長。
慢性病患病率上升
由於近年來癌症等慢性病的增加,到門診手術設施就診的患者人數也有所增加。 此外,由於患者選擇腹腔鏡治療的增加,預計在整個預測期內,外科縫合器市場將增長。 成本下降、住院時間縮短以及腹腔鏡手術的日益普及都歸因於這些因素。 因此,由於慢性病的高患病率和腹腔鏡手術的日益普及,預計手術吻合器的市場增長將激增。
市場製約因素
外科吻合器的常見問題
在傷口部位打開訂書釘線、訂書釘密封不良缺陷、訂書釘缺陷或卡紙、訂書釘未從訂書機射出、訂書釘未正確放置在錯誤的組織中、特定應用使用錯誤尺寸的訂書釘等,都是一些使用裝訂設備的常見問題。 這些問題的頻繁發生導致釘傷、更長的癒合時間以及更高的患者醫療和康復成本。 這些問題預計將限制吻合器的市場擴張。
產品類型展望
根據產品類型,外科吻合設備市場分為電動和手動。 到 2021 年,動力部分在手術吻合器市場中佔據了很大的收入份額。 這是由於無需體力即可方便地閉合傷口。 醫療保健專業人員現在可以通過各種尺寸的機動手術吻合器獲得更多選擇。 此外,技術進步、產品發布以及公司對開發動力裝訂設備的關注也是預計推動這一領域增長的因素之一。
按類型劃分的前景
按類型劃分,手術吻合器市場分為一次性和可重複使用。 2021 年,可重複使用部分將佔手術吻合器械市場的最高收入份額。 這是因為可重複使用的手術吻合器在消毒後可用於多名患者。 由於該產品成本低,預計該類別在發展中國家佔有更大份額。 此外,手術吻合器與可吸收吻合器相結合的引入預計將在預測期內推動該細分市場的擴張。
結束使用 Outlook
按最終用途,外科縫合設備市場分為醫院和門診手術中心。 2021 年,醫院部門在手術吻合器市場中的收入份額最大。 這是因為醫院看到的主要趨勢表明轉向了包括機器人手術在內的臨床效率模型。 微創手術可以受益於機器人手術。 醫院擁有訓練有素的員工和高科技設備,以確保安全和成功的程序。 由於不同方法的有利報銷條款,預計醫院類別在預測期內也將保持其主導地位。
區域展望
按地區劃分,對北美、歐洲、亞太地區和拉美地區的手術吻合器市場進行了分析。 2021 年,北美地區在手術吻合器市場的收入份額最高。 這是由於隨著手術總數的增加,尖端技術和微創手術的採用。 此外,世界上肥胖率最高的流行病、跨國公司在當地的存在以及政府對微創手術的批准也有助於佔據重要的市場份額。
市場進入者採取的主要策略是產品發布。 根據 Cardinal Matrix 中的分析,Johnson & Johnson (Ethicon) 是外科吻合器市場的領導者。 Intuitive Surgical, Inc.、Medtronic PLC 和 Stryker Corporation 等公司是外科吻合器市場的領先創新者。
The Global Surgical Stapling Devices Market size is expected to reach $7.9 billion by 2028, rising at a market growth of 9.4% CAGR during the forecast period.
Surgical stapling devices apply surgical staples instead of sutures to heal skin wounds or keep tissue together. When operating time is an issue and aesthetic closure is not a top priority, surgical staples may help close injuries quickly. There are now three main categories of mechanical staplers for open and endoscopic surgery: linear, circular, and endoscopic surgical staplers.
Several novel surgical equipment and gadgets are now available because of technological advancements in various scientific fields. To enhance patient outcomes, surgeons can create novel surgical procedures due to the constant introduction of new instruments and the ongoing technological advances in already-existing technologies.
In many instances, surgeons may need to learn the scientific or clinical foundation for the best use of these technologies or how to benefit from any particular advantages a specific technology may have. So, even if the devices work well, surgeons may often depend on their expertise, judgment, or anecdotal evidence for better results.
Equipment that is often employed during surgical operations and is also undergoing a nearly continual state of technological evolution is the surgical stapler. While these tools are adaptable and practical, there have been well-reported instances of staple line leaks that resulted in postoperative difficulties, many of which were caused by problems unrelated to ischemia.
In operations, particularly challenging ones like gynecologic, gastrointestinal, & bariatric procedures, surgical stapling instruments are becoming more and more crucial. In addition, the use of surgical stapling devices facilitates the development of novel surgical techniques, the alteration of existing procedures, and the enhancement of clinical results. The increasing demand for less invasive treatments globally drives the expansion of the surgical stapling devices market.
COVID-19 Impact Analysis
The lockdown compelled many hospitals to stop their outpatient departments for situations other than emergencies, which had a significant impact on the market for surgical stapling devices. Social exclusion, population control, and restricted clinic access substantially influenced the market. However, the market is anticipated to grow significantly after the lockdown restrictions are lifted as significant manufacturers are concentrating on introducing technologically cutting-edge items to increase their market share. Also, with production getting back on track, and the resume in surgical procedures which is increasing the demand, the surgical stapling devices market will start to expand again after the pandemic.
Market Growth Factors
The technological betterment of surgical stapling devices
Technological developments in surgical staples and related staples have significantly impacted the acceptance of surgical stapling devices by healthcare practitioners. With the introduction of powered surgical staplers, the time needed to seal the wound after surgery has decreased, minimizing problems and blood loss. In clinical testing, the powered surgical stapler performed better in the speed of healing and decreased discomfort. Hence, it is anticipated that the technical benefits offered by surgical stapling devices will drive market growth.
Rising prevalence of chronic diseases
Due to the rise in chronic illnesses like cancer during the last several years, there has also been an increase in the number of visits to ambulatory surgical facilities. Moreover, it is predicted that the market for surgical staplers will grow throughout the projection years due to the rise in laparoscopic treatments chosen by patients. The decreasing cost, shorter hospital stays, and increasing popularity of laparoscopic operations are all due to these factors. Hence with the high prevalence of chronic cases and the rising popularity of laparoscopic operations, the market growth for surgical stapling devices will surge.
Market Restraining Factors
Common issues with surgical staplers
Opening of the staple line at a wound site, faulty staples that result in insufficient sealing, defective or jammed staplers, failing to shoot a staple from a stapler, staples that were improperly positioned on the wrong tissue spot using a staple that is the incorrect size for a particular application are some of the common issues associated with the usage of stapling devices. These frequent issues may result in surgical staple wounds, lengthening healing time and exposing the patient to higher medical and rehabilitation expenses. These issues with the stapling devices are expected to restrict their market expansion.
Product Type Outlook
Based on product type, the surgical stapling devices market is segmented into powered and manual. The powered segment acquired a significant revenue share in the surgical stapling devices market in 2021. This is due to their simplicity of wound closure without requiring physical effort. Medical professionals now have more options due to the availability of powered surgical stapling devices in various sizes. In addition, the escalating technical advancements, product launches, and firms' increased emphasis on developing powered stapling devices are among other factors which are anticipated to boost the segment growth.
Type Outlook
On the basis of type, the surgical stapling devices market is divided into disposable and reusable. The reusable segment held the highest revenue share in the surgical stapling devices market in 2021. This is because reusable surgical stapling instruments may be used on several patients after sterilizing. Due to the product's low cost, the category is expected to have a bigger share in developing countries. Furthermore, the introduction of surgical stapling devices combined with absorbable staplers is projected to boost the segment expansion in the projected period.
End Use Outlook
By end-use, the surgical stapling devices market is classified into hospitals and ambulatory surgical centers. The hospitals segment witnessed the largest revenue share in the surgical stapling devices market in 2021. This is because hospitals are seeing a significant trend that points to a move towards clinical efficiency models, including robotic surgery. Minimally invasive procedures benefit from robotic surgery. The hospitals have well-trained staff and high-tech devices, which ensures a safe and successful procedure. Also, the hospital category is anticipated to maintain its dominance due to favorable reimbursement conditions for different methods during the projection period.
Regional Outlook
Region-wise, the surgical stapling devices market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region registered the highest revenue share in the surgical stapling devices market in 2021. This is owing to the employment of cutting-edge technology and minimally invasive procedures with the rising number of total operations. In addition, the greatest obesity prevalence in the world, the local presence of multinational corporations, and the government's clearance for minimally invasive operations are other factors contributing to the large market share.
The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; Johnson & Johnson (Ethicon, Inc.) is the forerunner in the Surgical Stapling Devices Market. Companies such as Intuitive Surgical, Inc., Medtronic PLC, and Stryker Corporation are some of the key innovators in Surgical Stapling Devices Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, Medtronic PLC, BioPro, Inc., ConMed Corporation, Smith & Nephew PLC, Intuitive Surgical, Inc., Johnson & Johnson (Ethicon, Inc.), B. Braun Melsungen AG, Becton, Dickinson and Company and Meril Life Science Private Limited.
Recent Strategies Deployed in Surgical Stapling Devices Market
Product Launches and Expansions:
Jun-2022: Ethicon, part of Johnson & Johnson introduced the ECHELON 3000 Stapler intended to use in resection, transection, and creation of anastomoses. The ECHELON 3000 is available in 45mm and 60mm staplers. The new stapler is a single-patient-use, sterile, that can cut and staple both at the same time.
May-2022: Stryker introduced the EasyFuse Dynamic Compression System, which will be a part of Stryker's foot and ankle product portfolio. The new staple system is developed using a nickel-titanium alloy metal, known as nitinol. The EasyFuse Dynamic Compression System decreases complexity in surgeries. The newly launched product features, a wide staple bridge, an intuitively developed inserter, and sterile-packed instrumentation.
Jun-2021: Intuitive unveiled SureForm, a robotic-assisted surgical stapler SureForm. The surgical stapler comes with SmartFire technology, an integrated software. The SureForm allows the surgeon to simultaneously fire the stapler from the console itself, and perform the RAS procedure. Further, the launch of the robot-assisted stapler reflects the company's advancement towards simplification of the surgery procedure.
Mar-2021: Ethicon, part of Johnson & Johnson launched ECHELON+ Stapler equipped with Gripping Surface Technology (GST) Reloads. The new surgical stapler is developed to enhance staple line security, and lower complications. The stapler is equipped with a new motor with dynamic firing and a restructured ECHELON+Anvil.
Dec-2020: Medtronic launched Tri-Staple EEA Circular Stapler in India. The 3-row circular stapler is equipped with Medtronic's Tri-Staple technology and has multiple height staples. The new circular stapler is intended to use in colorectal procedures. Additionally, the device is also equipped with enhanced tactile and audible feedback that allows clinicians to make a better informed decisions in the operating room.
Feb-2020: Smith+Nephew introduced the CORI Surgical system. The new surgical systems are intended to enhance outcomes during knee arthroplasty, and also increase accuracy. Additionally, the CORI system is portable and easy to move from one theatre to the other.
Geographical Expansions:
Nov-2022: Becton, Dickinson, and Company (BD) expanded its global footprint by setting up a new manufacturing facility in Tijuana, Mexico. The new facility would primarily manufacture devices and technologies. The establishment of the new facility demonstrates BD's devotion to Mexico and its strong relationship with communities across Mexico. This new plant would further simplify BD's operations by integrating a distribution center, a manufacturing site, and the transportation of products to the end consumer all in one place.
Aug-2022: Stryker opened a new facility in Ireland. The new high-tech facility is a 156,000-square-foot facility, which would reinforce the company's market position in additive manufacturing.
Jun-2022: Smith+Nephew opened a new manufacturing and R&D facility in Hull, United Kingdom. The new facility is intended for its advanced wound management franchise. The establishment of the new facility reflects the company's commitment to the UK and to building a leading market position in advanced wound management.
Jun-2022: Stryker expanded its global footprint by setting up a new R&D facility in Haryana, India. The new 150,000-square-foot facility would advance innovation. Further, Stryker's Global Technology Centre (SGTC) reinforces the company's potential to develop and design new products and solutions.
Trials and Approvals:
Dec-2021: Intuitive received FDA approval for its SureForm 30. SureForm 30 is an 8 mm curved-tip stapler. The curved stapler is intended to use in thoracic, general, pediatric, urologic, and gynecologic surgeries.
Acquisitions and Mergers:
Sep-2022: B. Braun took over Clik-FIX Catheter Securement Devices from Starboard Medical. The acquisition includes a Clik-FIX Peripheral catheter securement device, Clik-FIX Universal catheter securement device, a Clik-FIX Neonatal PICC catheter securement device, and Clik-FIX PICC/Central catheter securement device. The combination of the Clik-FIX portfolio and B.Braun's competence and deep knowledge enables the acquirer to fulfill the growing needs of its clients and further strengthens its market position in the IV therapy market.
Nov-2020: Medtronic took over Medicrea, a France-based company primarily into developing, manufacturing, and marketing orthopedic implants intended for spinal surgery. This acquisition would reinforce Medtronic's position in personalized implants' AI-based prediction and planning capabilities.
Partnerships, Collaborations and Agreements:
May-2022: Intuitive teamed up with Creo Medical Group, a UK-based medical device company. The collaboration includes optimizing Creo's products to make them consistent with Intuitive's robotic technology.
Market Segments covered in the Report:
By Type
By Product Type
By End-use
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures